Press release
Global Proprotein Convertase Subtilisin/Kexin Type 9 Market is Projected to Surpass USD 5.09 Billion By the End of 2030 with a Growing CAGR of 9.56% | Infinium Global Research
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/420
Market Insight:
The global Proprotein Convertase Subtilisin/Kexin Type 9 market, valued at USD 2.46 billion in 2022, is projected to surge to USD 5.09 billion by 2030, exhibiting an impressive CAGR of 9.56% during the forecast period from 2023 to 2030.
Market Dynamics:
The PCSK9 market revolves around medications targeting PCSK9, a key protein regulating cholesterol levels. These medications are pivotal in managing high cholesterol, particularly for individuals unresponsive to traditional cholesterol-lowering drugs or requiring additional therapy for healthy cholesterol levels.
Drivers and Growth Factors:
The market's growth is primarily propelled by the escalating concerns surrounding cardiovascular diseases. As a leading cause of global mortality, the focus on reducing LDL cholesterol is paramount in managing cardiovascular risk, making PCSK9 inhibitors increasingly sought after in cardiovascular risk management strategies. Moreover, the remarkable clinical effectiveness and high efficacy of PCSK9 inhibitors contribute significantly to their market growth. However, accessibility and high costs pose barriers to market expansion. Nonetheless, ongoing research and clinical trials offer promising prospects for PCSK9 inhibitors to garner expanded indications, potentially broadening their market scope.
Regional Market Insights:
North America is poised to dominate the PCSK9 market due to its high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and significant advancements by key market players. Conversely, the Asia Pacific region is projected to witness substantial growth during the forecast period. The region's rising demand for healthy food products, enhancing healthcare infrastructure, and growing awareness regarding heart diseases drive this market growth.
Segmentation Insights:
The report dissects segments encompassing products (SX-PCSK9, K-312, LY3015014, and others) and applications (cardiovascular disease, homozygous familial hypercholesterolaemia, liver disease, metabolic syndrome, and others).
Key Players Profiled:
Leading industry players such as Amgen Inc., Novartis AG, Eli Lilly and Company, Ensemble Therapeutics Corporation, Alnylam Pharmaceuticals, Inc., Regeneron Pharmaceuticals Inc., AFFiRiS AG, Merck & Co., Inc., Sanofi, and AstraZeneca and Company are profiled in the report, offering insights into their market strategies and positioning.
Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/420
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Proprotein Convertase Subtilisin/Kexin Type 9 Market Highlights
2.2. Proprotein Convertase Subtilisin/Kexin Type 9 Market Projection
2.3. Proprotein Convertase Subtilisin/Kexin Type 9 Market Regional Highlights
Chapter 3. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter`s Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Product
3.4.2. IGR-Growth Matrix Analysis by Application
3.4.3. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Market
Chapter 4. Proprotein Convertase Subtilisin/Kexin Type 9 Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Proprotein Convertase Subtilisin/Kexin Type 9 Market
5.2. Companies Profiles
5.2.1. Amgen Inc.
5.2.2. Novartis AG
5.2.3. Eli Lilly and Company
5.2.4. Ensemble Therapeutics Corporation
5.2.5. Alnylam Pharmaceuticals, Inc.
5.2.6. Regeneron Pharmaceuticals Inc.
5.2.7. AFFiRiS AG
5.2.8. Merck & Co., Inc.
5.2.9. Sanofi
5.2.10. AstraZeneca
Chapter 6. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
6.1. SX-PCK9
6.2. K-312
6.3. LY3015014
6.4. Others
Chapter 7. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
7.1. Cardiovascular Disease
7.2. Homozygous Familial Hypercholesterolaemia
7.3. Liver Disease
7.4. Metabolic Syndrome
7.5. Others
Chapter 8. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market by Region 2023-2030
8.1. North America
8.1.1. North America Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.1.2. North America Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.1.3. North America Proprotein Convertase Subtilisin/Kexin Type 9 Market by Country
8.1.3.1. The U.S. Proprotein Convertase Subtilisin/Kexin Type 9 Market
8.1.3.1.1. The U.S. Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.1.3.1.2. The U.S. Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.1.3.2. Canada Proprotein Convertase Subtilisin/Kexin Type 9 Market
8.1.3.2.1. Canada Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.1.3.2.2. Canada Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.1.3.3. Mexico Proprotein Convertase Subtilisin/Kexin Type 9 Market
8.1.3.3.1. Mexico Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.1.3.3.2. Mexico Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.2. Europe
8.2.1. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.2.2. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.2.3. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market by Country
8.2.3.1. Germany Proprotein Convertase Subtilisin/Kexin Type 9 Market
8.2.3.1.1. Germany Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.2.3.1.2. Germany Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.2.3.2. United Kingdom Proprotein Convertase Subtilisin/Kexin Type 9 Market
8.2.3.2.1. United Kingdom Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.2.3.2.2. United Kingdom Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.2.3.3. France Proprotein Convertase Subtilisin/Kexin Type 9 Market
8.2.3.3.1. France Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.2.3.3.2. France Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.2.3.4. Italy Proprotein Convertase Subtilisin/Kexin Type 9 Market
8.2.3.4.1. Italy Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.2.3.4.2. Italy Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.2.3.5. Rest of Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market
8.2.3.5.1. Rest of Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.2.3.5.2. Rest of Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.3. Asia Pacific
8.3.1. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.3.2. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.3.3. Asia Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Market by Country
8.3.3.1. China Proprotein Convertase Subtilisin/Kexin Type 9 Market
8.3.3.1.1. China Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.3.3.1.2. China Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.3.3.2. Japan Proprotein Convertase Subtilisin/Kexin Type 9 Market
8.3.3.2.1. Japan Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.3.3.2.2. Japan Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.3.3.3. India Proprotein Convertase Subtilisin/Kexin Type 9 Market
8.3.3.3.1. India Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.3.3.3.2. India Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.3.3.4. South Korea Proprotein Convertase Subtilisin/Kexin Type 9 Market
8.3.3.4.1. South Korea Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.3.3.4.2. South Korea Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.3.3.5. Australia Proprotein Convertase Subtilisin/Kexin Type 9 Market
8.3.3.5.1. Australia Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.3.3.5.2. Australia Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.3.3.6. Rest of Asia-Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Market
8.3.3.6.1. Rest of Asia-Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.3.3.6.2. Rest of Asia-Pacific Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.4. RoW
8.4.1. RoW Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.4.2. RoW Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.4.3. RoW Proprotein Convertase Subtilisin/Kexin Type 9 Market by Sub-region
8.4.3.1. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Market
8.4.3.1.1. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.4.3.1.2. Latin America Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.4.3.2. Middle East Proprotein Convertase Subtilisin/Kexin Type 9 Market
8.4.3.2.1. Middle East Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.4.3.2.2. Middle East Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
8.4.3.3. Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market
8.4.3.3.1. Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market by Product
8.4.3.3.2. Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market by Application
More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/420
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9).
=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.
=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.
2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027
About Infinium Global Research:
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Proprotein Convertase Subtilisin/Kexin Type 9 Market is Projected to Surpass USD 5.09 Billion By the End of 2030 with a Growing CAGR of 9.56% | Infinium Global Research here
News-ID: 3319712 • Views: …
More Releases from Infinium Global Research LLP
Infinium Global Research LLP Launches Comprehensive Service to Assist Foreign Co …
Pune, India - October 26, 2024 - Infinium Global Research LLP is excited to announce the launch of a dedicated service aimed at providing end-to-end support for foreign companies entering or expanding within the Indian market. With a strategic network of partnerships with top legal and consulting firms and increased presence across key Indian cities, Infinium is well-equipped to facilitate smooth market entry, operational setup, and business expansion for international…
Global Sterilization Services Market Size Worth USD 12.55 Billion By 2030 | CAGR …
Infinium Global Research, a leading provider of market intelligence, has recently launched an in-depth report on the Global Sterilization Services Market, offering comprehensive analysis and detailed insights into its segments and market trends.
The comprehensive study explores the impact of various factors such as drivers, restraints, and macro indicators on both the global and regional sterilization services market, providing crucial forecasts and dollar value projections.
To Know More Request a Sample of…
Global Neuromodulation Market is Anticipated to Reach USD 7.27 Billion and Growi …
Infinium Global Research, a pioneering market intelligence firm, introduces a comprehensive report delving into the Global Neuromodulation Market, providing extensive analysis and in-depth exploration of its segments, market trends, and projections.
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/93
Market Insight:
The global neuromodulation market, valued at USD 3.51 Billion in 2022, is poised to ascend to USD 7.27 Billion by 2030, exhibiting a noteworthy CAGR of 9.59% during the forecast…
Global Botulinum Toxin Market Growing at a CAGR of 9.12% to Reach USD 20.09 Bill …
Infinium Global Research, a leading market intelligence firm, has released an extensive report delving into the dynamics and trends shaping the Global Botulinum Toxin Market. This comprehensive analysis spans both the global landscape and regional perspectives, providing invaluable insights into the market's trajectory, influencing factors, and growth projections.
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/89
Market Insight:
The global botulinum toxin market, valued at USD 10.02 billion in 2022, is…
More Releases for Proprotein
PCSK9 Inhibitors Clinical Trials 2024: FDA Approvals, Medication, Treatment Mark …
(Nevada, United States) As per DelveInsight's assessment, globally, PCSK9 Inhibitors pipeline constitutes 14+ key companies continuously working towards developing 14+ PCSK9 Inhibitors treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"PCSK9 Inhibitors Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the PCSK9 Inhibitors Market.
The PCSK9 Inhibitors Pipeline report embraces in-depth commercial…
Proprotein Convertase Subtilisin Kexin Type 9 Market Growth Trends Regional Anal …
The Proprotein Convertase Subtilisin Kexin Type 9 Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.
Get a Free Sample PDF - https://www.datamintelligence.com/download-sample/-proprotein-convertase-subtilisin-kexin-type-9-market
The Global "Proprotein Convertase Subtilisin/Kexin Type 9 Market" is…
Proprotein Convertase Subtilisin/Kexin Type 9 Market Expected to Reach Huge Grow …
DataM Intelligence has released a new research report on the Proprotein Convertase Subtilisin/Kexin Type 9 market. The report provides a detailed analysis of current and emerging trends, offering insights into the market dynamics. It utilizes Porter's Five Forces model to assess key factors such as supplier and customer relationships, risks from various agents, competitive intensity, and opportunities for new entrants. The study also includes research data from various companies, analyzing…
PCSK9 Inhibitor Pipeline Assessment 2024: Clinical Trials, FDA Approvals, Therap …
(Albany, United States) As per DelveInsight's assessment, globally, the PCSK9 Inhibitor Pipeline constitutes 14+ key companies continuously working towards developing 14+ PCSK9 Inhibitor Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the PCSK9 Inhibitor Pipeline Report, a detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, PCSK9 Inhibitor NDA approvals (if any),…
PCSK9 Inhibitor Pipeline Insights Report 2024
(Albany, United States) As per DelveInsight's assessment, globally, the PCSK9 Inhibitor Pipeline constitutes 14+ key companies continuously working towards developing 14+ PCSK9 Inhibitor Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the PCSK9 Inhibitor Pipeline Report, a detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, PCSK9 Inhibitor NDA approvals (if any),…
PCSK9 Inhibitor Pipeline Insights Report 2023 (Updated) | Ionis Pharmaceuticals, …
(Albany, United States) As per DelveInsight's assessment, globally, the PCSK9 Inhibitor Pipeline constitutes 14+ key companies continuously working towards developing 14+ PCSK9 Inhibitor Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the PCSK9 Inhibitor Pipeline Report, a detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, PCSK9 Inhibitor NDA approvals (if…
